EC Number   |
Disease |
PubMed ID  |
Title of Publication |
Category |
Confidence Level |
|---|
    1.1.3.15 | Urolithiasis |
615128 |
Experimental urolithiasis : Part II--a comparative kinetic study of glyoxalase I, glycolate oxidase, alkaline phosphatase & lactate dehydrogenase in the normal rat kidney & bladder & its alterations in urolithiasis. |
diagnostic usage
ongoing research
unassigned |
3
2
0 |
| 1.1.3.15 | Neoplasms |
6893680 |
Oxidoreductase activities in normal rat liver, tumor-bearing rat liver, and hepatoma HC-252. |
causal interaction
diagnostic usage
ongoing research
unassigned |
4
3
1
0 |
| 1.1.3.15 | Vitamin B 6 Deficiency |
7051948 |
Vitamin B6 deficiency as related to oxalate-synthesizing enzymes in growing rats. |
causal interaction
ongoing research
unassigned |
2
4
0 |
| 1.1.3.15 | Hyperoxaluria |
7853865 |
Effect of Tribulus terrestris on oxalate metabolism in rats. |
unassigned |
0 |
| 1.1.3.15 | Glioma |
8996517 |
L-amino acid oxidase (LOX) modulation of melphalan activity against intracranial glioma. |
causal interaction
ongoing research
therapeutic application
unassigned |
2
2
2
0 |
| 1.1.3.15 | Colorectal Neoplasms |
9304806 |
Characterization and cytotoxicity of L-amino acid oxidase from the venom of king cobra (Ophiophagus hannah). |
diagnostic usage
ongoing research
unassigned |
1
4
0 |
| 1.1.3.15 | Fibrosarcoma |
9304806 |
Characterization and cytotoxicity of L-amino acid oxidase from the venom of king cobra (Ophiophagus hannah). |
diagnostic usage
ongoing research
unassigned |
1
4
0 |
| 1.1.3.15 | Melanoma |
9304806 |
Characterization and cytotoxicity of L-amino acid oxidase from the venom of king cobra (Ophiophagus hannah). |
diagnostic usage
ongoing research
unassigned |
1
4
0 |
| 1.1.3.15 | Stomach Neoplasms |
9304806 |
Characterization and cytotoxicity of L-amino acid oxidase from the venom of king cobra (Ophiophagus hannah). |
diagnostic usage
ongoing research
unassigned |
1
4
0 |
| 1.1.3.15 | Hyperoxaluria |
12110000 |
Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or II. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
2
1 |
